2026 ICD-10-CM Diagnosis Code N95.2Postmenopausal atrophic vaginitis

ICD-10-CM Codes›N00–N99›N80-N98›N95

ICD-10-CM N95.2
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

N95.2 is a billable ICD-10-CM diagnosis code for postmenopausal atrophic vaginitis. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 742 through 743, 760 through 761. Coders also document this condition as atrophic vaginitis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Menopausal disorders and Other specified female genital disorders.

This medical diagnosis code is frequently used in OB/GYN medical specialties to designate conditions such selected menopausal and other perimenopausal disorders.

Code Identity

ICD-10-CM Code
N95.2
Billable Status
Yes — Valid for Submission
Code Describes
Postmenopausal atrophic vaginitis
Short Description
Postmenopausal atrophic vaginitis
Same as the full description in the CMS dataset.
Parent Code
N95
Menopausal and other perimenopausal disorders

Code Classification

ChapterN00–N99Diseases of the genitourinary system
SectionN80-N98Noninflammatory disorders of female genital tract
CategoryN95Menopausal and other perimenopausal disorders
This CodeN95.2Postmenopausal atrophic vaginitis

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Atrophic vaginitis
  • Atrophic vulvovaginitis
  • Atrophy of vagina
  • Perimenopausal atrophic vaginitis
  • Vaginitis
  • Vulvovaginitis

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Senile (atrophic) vaginitis

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Atrophy, atrophic(of)
      • vagina (senile)
    • Senile, senility
      • vagina, vaginitis (atrophic)
    • Vaginitis(acute) (circumscribed) (diffuse) (emphysematous) (nonvenereal) (ulcerative)
      • atrophic, postmenopausal
    • Vaginitis(acute) (circumscribed) (diffuse) (emphysematous) (nonvenereal) (ulcerative)
      • postmenopausal atrophic
    • Vaginitis(acute) (circumscribed) (diffuse) (emphysematous) (nonvenereal) (ulcerative)
      • senile (atrophic)

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR GEN023
Menopausal disorders
Default principal diagnosis: inpatient Yes · outpatient Yes
CCSR GEN025
Other specified female genital disorders
Default principal diagnosis: inpatient No · outpatient No

Clinical InformationClinical

  • Atrophic Vaginitis

    inflammation of the vagina due to thinning of the vaginal wall and decreased lubrication associated with reduced estrogen levels at menopause.

  • Candidiasis, Vulvovaginal

    infection of the vulva and vagina with a fungus of the genus candida.

  • Trichomonas Vaginitis

    inflammation of the vagina, marked by a purulent discharge. this disease is caused by the protozoan trichomonas vaginalis.

  • Vaginitis

    inflammation of the vagina characterized by pain and a purulent discharge.

  • Vaginosis, Bacterial

    polymicrobial, nonspecific vaginitis associated with positive cultures of gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. it remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli.

  • Vulvovaginitis

    inflammation of the vulva and the vagina, characterized by discharge, burning, and pruritus.

  • Menopause

    the last menstrual period. permanent cessation of menses (menstruation) is usually defined after 6 to 12 months of amenorrhea in a woman over 45 years of age. in the united states, menopause generally occurs in women between 48 and 55 years of age.

  • Trichomonas vaginalis

    a species of trichomonas that produces a refractory vaginal discharge in females, as well as bladder and urethral infections in males.

  • Herpetic Vulvovaginitis

    infection of the vulva and the vagina caused by herpes simplex virus.

  • Vulvovaginitis

    an inflammatory pathologic process that affects the vulva and the vagina.

Patient EducationClinical

Menopause

Menopause is the time in your life when you stop having your period and can no longer get pregnant. You have reached menopause when you have not had a period for 12 months.

The full article covers:

  • What is menopause?
  • What is early menopause?
  • What are the symptoms of menopause?
  • What are the treatments for the symptoms of menopause?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert N95.2 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
627.3 Atrophic vaginitis
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About N95.2Overview

Is N95.2 (Menopausal and other perimenopausal disorders) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report postmenopausal atrophic vaginitis on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does N95.2 group to?

When postmenopausal atrophic vaginitis is the principal diagnosis on an inpatient stay, it groups to MS-DRG 742, 743, 760, 761, with relative weights from 0.5696 to 1.8348 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of N95.2?

Under the General Equivalence Mappings, postmenopausal atrophic vaginitis converts to ICD-9-CM 627.3 (atrophic vaginitis). The mapping is a direct match.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.